Fact CheckerSign in

NCT05866744Completed

Effects of Time-restricted Hypocaloric Diet in Patients with NAFLD

Effects of a Time-restricted Hypocaloric Mediterranean Diet in Patients with Non-alcoholic Fatty Liver Disease on Glucose Metabolism (CHRONO-NAFLD Project)

Source: ClinicalTrials.gov · Last updated 30 Oct 2024

Brief summary (registry, in English)

The effects of a time-restricted hypocaloric Mediterranean type diet compared to a conventional hypocaloric Mediterranean type diet on blood glucose metabolism and liver steatosis in people with non-alcoholic fatty liver disease will be investigated.

Status (registry)
Completed
Study type
Interventional
Enrollment
59 (actual)
First submitted
30 Mar 2023
Start date
8 May 2023
Primary completion date
15 Jul 2024
Lead sponsor
Agricultural University of Athens
NCT number
NCT05866744

What you commit to

  • Study type: Interventional
  • Participants enrolled: 59
  • From 8 May 2023 to the primary completion date, 15 Jul 2024
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Statins and/ or other fat-reducing medications if not taken in steady dosage for at least 3 months

Other illness

  • Other chronic liver diseases
  • Medications that cause liver disease or secondary NAFLD (e.g. tamoxifen, corticosteroids, Methotrexate, tetracycline, estrogens, valproic acid)
  • Body weight lowering medications and/or history of bariatric surgery
  • Immunologic or inflammatory diseases
  • Depression and other psychiatric diseases
  • Cancer

Lab values

  • Unstable glucose-lowering medications in the last 6 months
  • Uncontrolled type 2 diabetes mellitus defined as HbA1c value \> 9.0% or insulin depending type 1 and 2 diabetes mellitus

Other

  • Alcohol consumption \>20 g/day (female) and \>30 g/day (male)
  • Changes in body weight ± 3 % in the last 3 months
  • Patients following a hypocaloric diet program and/or time-restricted feeding and/or other intermittent fasting protocols
  • Pregnancy
  • Lactation
  • Patients working in shifts

Who the study is looking for

  • Body Mass Index \>25 kg/m2
  • Liver steatosis with Magnetic Resonance Elastography (MRE)

Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Laiko General Hospital of Athens
Coordinator of this site? Confirm its status
AthensGreeceUnknown status
Agricultural University of Athens
Coordinator of this site? Confirm its status
AthensGreeceUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.